Potential mechanisms underlying CDK5 related Osteosarcoma progression.

about

Potential mechanisms underlying CDK5 related Osteosarcoma progression.

Item

http://www.wikidata.org/entity/Q51092343

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Potential mechanisms underlying CDK5 related Osteosarcoma progression.

@en

Potential mechanisms underlying CDK5 related Osteosarcoma progression.

@nl

type

Item

label

Potential mechanisms underlying CDK5 related Osteosarcoma progression.

@en

Potential mechanisms underlying CDK5 related Osteosarcoma progression.

@nl

prefLabel

Potential mechanisms underlying CDK5 related Osteosarcoma progression.

@en

Potential mechanisms underlying CDK5 related Osteosarcoma progression.

@nl

P1476

Potential mechanisms underlying CDK5 related Osteosarcoma progression.

@en

P2093

Chen Zhao

http://www.w3.org/2001/XMLSchema#string

Hai Zou

http://www.w3.org/2001/XMLSchema#string

Hang-Xing Bao

http://www.w3.org/2001/XMLSchema#string

Qing Bi

http://www.w3.org/2001/XMLSchema#string

Yong Han

http://www.w3.org/2001/XMLSchema#string

P2860

NCBI GEO: archive for functional genomics data sets--update

The role of Cdk5 in neuroendocrine thyroid cancer

Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis

GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop

From Krebs to clinic: glutamine metabolism to cancer therapy.

Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Cdk5 promotes DNA replication stress checkpoint activation through RPA-32 phosphorylation, and impacts on metastasis free survival in breast cancer patients.

SRCIN1 Suppressed Osteosarcoma Cell Proliferation and Invasion.

Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival

P304

455-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14728222.2017.1310194

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28323497

http://www.w3.org/2001/XMLSchema#string